Assessing the causality of interferon‐γ and its receptor 1/2 with systemic lupus erythematosus risk using genetic data
Rheumatology & Autoimmunity · 2024-06 · 4 (2) · 109-118
DOI: 10.1002/rai2.12125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology & Autoimmunity, online erschienen am 13.05.2024. Verfasst von Minjing Chang und 7 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The interferon‐γ (IFN‐γ) signaling pathway is activated in systemic lupus erythematosus (SLE). This study aimed to assess the causal association between IFN‐γ, IFN‐γ receptor 1 (IFN‐γR1), and IFN‐γR2 and SLE using a bidirectional Mendelian randomization (MR) design.
Methods
Genetic instruments for exposure to IFN‐γ, IFN‐γR1, and IFN‐γR2 were derived from a large genome‐wide association study (GWAS) that included a sample size of 3301 participants. Instrumental variables for SLE were selected from another independent GWAS analysis comprising 5201 cases and 6099 controls with European ancestry. Bidirectional two‐sample MR was performed using inverse variance weighting, MR‐Egger regression, and weighted median methods. A series of sensitivity analyses were conducted to assess the robustness of the results.
Results
The inverse variance weighting showed that IFN‐γ had a positive causal association with the risk of SLE (odd ratio [OR] = 1.24, 95% confidence interval [CI]: 1.03–1.47, p = 0.018). IFN‐γR2 levels were not associated with SLE risk after adjustment for multiple comparisons (OR = 0.85, 95% CI: 0.73–0.99, p = 0.034). No genetic association was also detected between IFN‐γR1 and SLE (OR = 0.97, 95% CI: 0.79–1.19, p = 0.768). Evidence from bidirectional MR did not support reverse causality. The weighted median regression also showed directionally similar estimates.
Conclusion
Higher levels of IFN‐γ are significantly associated with an increased risk of SLE, providing insights into the pathogenesis of SLE.
Zitieren
APA
Chang, M., Yao, K., Hao, J., Long, Y., Qiao, L., Zhang, Y., Ma, K., & He, P. (2024). Assessing the causality of interferon‐γ and its receptor 1/2 with systemic lupus erythematosus risk using genetic data. Rheumatology & Autoimmunity, 4(2), 109-118. https://doi.org/10.1002/rai2.12125
Vancouver
Chang M, Yao K, Hao J, Long Y, Qiao L, Zhang Y, et al. Assessing the causality of interferon‐γ and its receptor 1/2 with systemic lupus erythematosus risk using genetic data. Rheumatology & Autoimmunity. 2024;4(2):109-118. doi:10.1002/rai2.12125
BibTeX
@article{Chang2024,
author = {Chang, Minjing and Yao, Kaixin and Hao, Jiawei and Long, Yinqi and Qiao, Lulin and Zhang, Yaru and Ma, Kexin and He, Peifeng},
title = {Assessing the causality of interferon‐γ and its receptor 1/2 with systemic lupus erythematosus risk using genetic data},
journal = {Rheumatology & Autoimmunity},
year = {2024},
volume = {4},
number = {2},
pages = {109--118},
doi = {10.1002/rai2.12125}
}
EUVIMED